Amgen EVP granted RSUs and stock options
Amgen EVP Murdo Gordon reported new equity awards and a small tax-related share withholding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amgen EVP Murdo Gordon reported new equity awards and a small tax-related share withholding. On May 5, 2026, he received 3,640 Restricted Stock Units (RSUs) that vest in four equal annual installments of 25% starting on May 5, 2027, and will be settled in common shares. These RSUs include 458 Dividend Equivalents credited under Amgen’s Equity Incentive Plan. He was also granted 23,752 non-qualified stock options with a $329.59 exercise price, vesting 25% annually from May 5, 2027, and expiring on May 5, 2036. On May 6, 2026, 502 shares of common stock were disposed of at $329.59 per share to satisfy tax obligations, a non-market "F" code withholding. After these transactions, Gordon directly holds 51,837 Amgen common shares.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Gordon Murdo
Role
EVP, Global Commercial Ops
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 502 | $329.59 | $165K |
| Grant/Award | Nqso (Right to Buy) | 23,752 | $329.59 | $7.83M |
| Grant/Award | Common Stock | 3,640 | $0.00 | $0.00 |
Holdings After Transaction:
Nqso (Right to Buy) — 23,752 contracts (Direct);
Common Stock — 51,837 shares (Direct)
Footnotes (3)
- F1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- F2. These shares include 458 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- F3. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Key Figures
RSU grant: 3,640 shares
Dividend Equivalents: 458 units
Stock options granted: 23,752 options
+5 more
8 metrics
RSU grant
3,640 shares
Restricted Stock Units granted May 5, 2026
Dividend Equivalents
458 units
Credited to unvested RSUs under Equity Incentive Plan
Stock options granted
23,752 options
Non-qualified stock options granted May 5, 2026
Option exercise price
$329.59/share
Conversion or exercise price for new options
Option expiration
May 5, 2036
Non-qualified stock options expiry date
RSU vesting rate
25% annually
Four annual installments starting May 5, 2027
Tax withholding shares
502 shares
Shares disposed at $329.59 to satisfy tax liability
Post-transaction holdings
51,837 shares
Common stock directly owned after reported transactions
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), non-qualified stock options, Equity Incentive Plan, +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 458 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan"
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Amgen (AMGN) grant to EVP Murdo Gordon?
Amgen granted EVP Murdo Gordon 3,640 Restricted Stock Units and 23,752 non-qualified stock options. The RSUs vest 25% annually from May 5, 2027, and the options have a $329.59 exercise price and expire on May 5, 2036.
How do Murdo Gordon’s new Amgen (AMGN) RSUs vest over time?
Murdo Gordon’s 3,640 Restricted Stock Units vest in four equal annual installments of 25% each. Vesting begins on May 5, 2027, and each vested unit will be paid out in one share of Amgen common stock under the company’s equity plan.
What are the terms of Murdo Gordon’s new Amgen (AMGN) stock options?
Gordon received 23,752 non-qualified stock options with a $329.59 exercise price. These options vest and become exercisable in four equal 25% annual installments starting May 5, 2027, and they expire on May 5, 2036, if not exercised earlier.
What are Dividend Equivalents (DEs) in Murdo Gordon’s Amgen (AMGN) filing?
Dividend Equivalents are credits tied to unvested RSUs that mirror dividends on Amgen shares. Gordon’s holdings include 458 DEs, which will be paid in Amgen common stock on a one-to-one basis at vesting, plus cash for any remaining fractional share amount.
AI-generated analysis. How Rhea-AI works. Not financial advice.
